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Background: Within a feasibility study the use of antibiotics in pigs and cattle was determined in 24 veterinary
practices in Lower Saxony and on 66 farms in North Rhine-Westphalia in Germany. Focus was laid on the
comparison of the Used Daily Doses (UDD) (dose per animal and day prescribed by the veterinarians) with the
Defined Animal Daily Doses (ADD) (dose per animal and day calculated by means of recommended dosages and
estimated live weights).
Results: For piglets and calves most of the UDD (50% and 46% of nUDD, respectively) were above the ADD
(i.e. UDD/ADD-ratio above 1.25). Regarding sows, fattening pigs, dairy and beef cattle, most of the UDDs
(49% to 65% of nUDD) were lower than the respective ADD (i.e. UDD/ADD-ratio below 0.8). In pigs, the UDDs of
beta-lactams, fluoroquinolones and cephalosporins, and in cattle, those of macrolides and beta-lactams were
often below the ADDs. Tetracyclines were frequently used above the recommended dose.
Enteric diseases were more often treated below the recommended dose than respiratory diseases, possibly due
to overestimation of the live weight (diarrhea in young animals, respiratory diseases in elder animals) and
consequently overestimation of the recommended dose.
Conclusion: Comparisons between UDD and ADD can be used to observe differences between antimicrobials
and trends in the usage of antibiotics. But individual treatment comparisons of UDD and ADD must be interpreted
carefully, because they may be due to lower live weights than estimated. Correlating such data with data on the
occurrence of resistant bacteria in future may help to improve resistance prevention and control.
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Use of antibiotics causes the risk of selecting for resist-
ant bacteria [1,2]. In order to avoid resistances and to
ensure therapeutic efficacy prudent use of antimicrobials
is necessary [3]. In Germany, the respective guidelines
were published by the working group “veterinary drugs”
of the Federal Veterinary Chamber [4].* Correspondence: roswitha.merle@gmail.com
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resistance monitoring has to be supplemented by the
collection of data on the antibiotic use in humans as well
as in the veterinary sector [5]. The German Antibiotic
Resistance Strategy DART released by the German
ministries in 2008 identified the collection of sales and
consumption data as one of the measures which should
be taken to control antibiotic resistances in human and
veterinary medicine [6]. The European Medicines Agency
EMA initiated the European Surveillance of Veterinary
Antimicrobial Consumption ESVAC, a project which col-
lects sales data from EU member states in a harmonizedtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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countries, participation increased in 2010 to 19 countries
[10] and in 2011 to 25 countries [11]. In this project, a de-
crease in the consumption of antibiotics by 8.2% between
2005 and 2009 was observed, between 2010 and 2011 the
decline varied from 0 to 28% in the regularly participating
countries. However, the authors stated that this decrease
may be due to antimicrobials with high dosages (e.g. tetra-
cyclines) having been replaced by antimicrobials with
lower dosages, e.g., fluoroquinolones, cephalosporins, and
pleuromutilins. The animal population per country was
expressed as population correction units (PCU) which
relates the numbers of animals per animal species to the
respective live weights. The calculated results in mg per
PCU differed widely between the countries in nearly all
antimicrobial classes, accounted for in part by different
distributions of animal species. Countries with a high
percentage of pigs seem to use more mg active ingre-
dients per PCU than others. The impact of tetracy-
clines (mg/PCU) ranged from 4 to 59% of all mg/PCU
(average 39%), while cephalosporins reached an average
of 0.5% of all mg/PCU.
Currently, some Scandinavian countries like Denmark
[12], Sweden [13], and Norway [14] collect data from
pharmacies, distributors and the pharmaceutical indus-
try, which reflect the amount of antimicrobials used in
the individual animal populations. In contrast to this, in
Germany, within a scientific study [15] data were
collected on the amount used by veterinarians as well as
the number of treatments. This was possible, as veteri-
narians sell antimicrobials directly to the farmer, and
detailed records are kept on this. In other European
countries veterinarians distribute drugs directly as well,
e.g., in France, Austria, the United Kingdom and in
Switzerland [16-20]. In Austria, sales data are collected
on a mandatory basis, but data on antibiotic use are
evaluated completely only for poultry, and on study basis
for cattle and pigs [9,20]. In the Netherlands, the situ-
ation is similar to that in Austria with complete sales
data, complete consumption data in poultry and study
data for pigs and cattle [21]. In Switzerland, complete
data on sales and study data on consumption are
available as well [10,11,16,20].
Denmark has very strict regulations regarding the
documentation of antibiotic use in livestock. Veterinarians
have to enter all cases of application of antibiotics into a
database. The degree to which prescription data are
currently used for quantification of antimicrobial usage is
varying between these countries.
Detailed data on the use of antibiotics in farm animals
– e.g., by species, age and number of animals, indication
of treatment and treatment duration – can only be col-
lected and evaluated when respective farm characteris-
tics as well as prescription details are known.Three general concepts are available for analyzing the
data and quantifying the antibiotic use. First, the amount
of active ingredients per se can be used. This variable is
precise, but must be regarded separately for each anti-
microbial [22] and depends very much on the population
size and type of production considered. Secondly, the
frequency of applications, e.g., the number of Used Daily
Doses (nUDD), can be calculated, if detailed application
data are available [23]. The third option is to estimate an
application frequency by sales or usage data, if appli-
cation details are not available. Several concepts from
different countries exist for calculating this third option,
e.g., Defined Animal Daily Doses (ADD) in Denmark
[12,22] and in the Netherlands [21].
Usually, this type of data is used for estimating the
number of Defined Animal Daily Doses (nADD) by
dividing the amount per antimicrobial used by the previ-
ously fixed Animal Daily Dose (ADD), which is the
product of expected dosage and the average animal
weight. If more detailed data are collected, the number
of Used Daily Doses (nUDD = number of animals treated
multiplied by the treatment days and the number of
active ingredients in the product) or the number of
Prescribed Daily Dose (nPDD) per livestock unit and per
ATCVetCode can be calculated [24].
One study from Belgium compared nUDD and nADD
regarding treatment incidences and showed only slight
differences [25]. Other studies also use UDD and ADD for
dosage comparisons. Regula et al. investigated prescription
patterns of antimicrobials in veterinary practices in
Switzerland and observed that most of the prescriptions
were dosed within the recommended range in cattle and
calves as well as in fattening pigs [26]. Overdosing was
seen in adult pigs and dogs. Dosage patterns differ
between antimicrobial classes with common dosage above
the recommended range for tetracyclines, and underdos-
ing for sulfonamides, aminoglycosides and quinolones.
González et al. [27] found similar results on Swiss dairy
farms with 30 – 55% underdosing depending on anti-
microbial classes and overdosing of cephalosporins,
sulfonamides & trimethoprim and macrolides. Pardon
et al. [28] reported underdosing in 43.7% of treatments in
veal calves. In a study of 50 pig herds in Belgium, the au-
thors stated that parenteral treatment was generally over-
dosed, while oral applications were often underdosed [29].
In order to evaluate the preconditions for a German
monitoring system of veterinary antibiotic use, a feasibil-
ity study “VetCAb” (Veterinary consumption of antibi-
otics) was carried out that collected consumption data
in a bottom-up approach [15]. Parts of the study that
concern the UDD per animal and year as well as the
administration routes have already been published [15].
The aim of the analysis presented here focuses on
comparing the number of UDDs with the number of
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and to discuss the impact of the type of indicator calcu-
lated on the interpretation of the usage patterns by
animal groups. For this purpose, also UDD/ADD-ratios
for administration routes and indications were calculated
separately. As on EU level only data on nADDs might be
available in the future [30], it is discussed whether the
calculating nADD has major pitfalls for assessing of the
antibiotic use in livestock.
Methods
Data from the feasibility study in Germany, already
previously described [15] were used for this additional
analysis. Briefly, in the study were 24 veterinary surgeries
as well as 66 livestock farms involved. All applications of
antibiotics of a one-year-period (September 1, 2006 –
August 31, 2007) were assessed [15]. The data sources
were the veterinarians’ official application records fol-
lowing article 13 of the Regulation of Veterinary
Pharmacies [31]. These documents contain information
on animal species, age and number of animals, the trade
name of the pharmaceutical drug and the amount (ml, g
or injectors) as well as the indication, pharmaceutical
form, and duration of the treatment for every drug
administered separately.
In order to validate the identity and amount of the ad-
ministered drugs relevant data from the system of the Vet-
erinary Information Service for Drug Use, Toxicology and
Pharmaceutical Legislation VETIDATA (www.vetidata.de)
were made available to the study database for background
information on the drugs.
All analyses were carried out for the individual antimi-
crobials and antimicrobial classes. For each record the
administered or prescribed amount of active ingredientTable 1 Percentages of records and nUDDs with doses below
feasibility study of antibiotic use in Germany including 19 ve
Records %
nUDD % % Recor
Macrolides 984 7.7 1599436 12.2 24.7
Beta-Lactams 4879 38.3 2942528 22.4 38.6
Aminoglycosides 725 5.7 308031 2.3 55.6
Fenicoles 158 1.2 18798 0.1 1.9
Tetracyclines 1841 14.4 2943293 22.4 25.1
Lincosamides 542 4.2 478013 3.6 40.8
Polypeptides 1285 10.1 1942674 14.8 24.6
Sulfonamides 707 5.5 2222599 16.9 27.6
Fluoroquinolones 882 6.9 144637 1.1 26.0
Cephalosporins 497 3.9 143417 1.1 23.5
Pleuromutilines 255 2.0 384482 2.9 46.3
All 12755 100.0 13127908 100.0 32.9was calculated. The number of used daily doses nUDD
was defined as the number of animals treated multiplied
by the treatment days (both noted in the record) and by
the number of active ingredients in the product. The
Used Daily Dose UDD was calculated as g active ingredi-
ents per animal and day for each antimicrobial per
record (amount active ingredients per antimicrobial di-
vided by number of animals treated and treatment days).
The number of Defined Animal Daily Doses nADD was
calculated according to Merle et al. [15] and Jensen et al.
[22]. In short, the Defined Animal Daily Dose ADD for
each antimicrobial and production type was calculated
by multiplying the recommended dosage for this anti-
microbial and the standard weight for the species,
weight group/production type for the respective animal
production type. Dividing the amount of active ingredi-
ents per record by this ADD resulted in the nADD. The
standard weight for the animal species, weight group/
production type was derived from estimated live weights
at treatment of livestock as defined according to Merle
et al. [15] and MARAN 2007 [32] as follows: sows
220 kg, suckling piglets 12.5 kg, weaners 25 kg, finishers
70.2 kg, cows and bulls 600 kg, calves 80 kg. The recom-
mended dosage (mg active substance/kg live weight and
day) was defined for both parenteral and oral application
separately for the species cattle and pigs on the basis of
the Summary of Product Characteristics (SPC) and in
some cases are based on information from the scientific
literature and expert opinions as laid down in the VETI-
DATA system.
In order to compare usage patterns for different
animal groups, antimicrobials, administration routes and
indications, for each record the UDD was divided by the
ADD to obtain the UDD/ADD-ratio per record. Ratios, within and above the recommended doses in piglets in a
terinary practices and 26 farms
Below Within Above
ds % nUDD % Records % nUDD % Records % nUDD
51.2 23.0 18.2 52.3 30.6
32.1 15.9 15.6 45.5 52.2
26.1 7.6 3.6 36.8 70.3
14.0 26.6 30.9 71.5 55.1
26.0 21.2 27.5 53.7 46.4
56.8 38.9 15.7 20.3 27.5
20.2 20.2 19.1 55.3 60.7
15.6 25.2 21.5 47.2 62.9
41.0 18.5 23.2 55.6 35.8
39.4 5.4 4.8 71.0 55.8
57.6 29.4 26.7 24.3 15.7
30.2 18.8 20.2 48.3 49.7
Table 2 Percentages of records and nUDDs with doses below, within and above the recommended doses in sows in a
feasibility study of antibiotic use in Germany including 19 veterinary practices and 26 farms
Records % Below Within Above
nUDD % % Records % nUDD % Records % nUDD % Records % nUDD
Macrolides 163 2.8 24581 3.4 43.6 82.7 33.7 14.5 22.7 2.8
Beta-Lactams 1832 31.4 159867 22.3 36.7 82.2 26.3 10.4 37.0 7.3
Aminoglycosides 359 6.2 7658 1.1 55.7 83.4 8.9 4.3 35.4 12.3
Fenicoles 78 1.3 1074 0.1 17.9 39.9 46.2 45.3 35.9 14.9
Tetracyclines 617 10.6 340661 47.5 32.4 56.9 21.9 17.3 45.7 25.9
Lincosamides 180 3.1 17671 2.5 71.1 94.8 15.6 2.4 13.3 2.8
Polypeptides 162 2.8 39314 5.5 84.6 75.5 10.5 12.8 4.9 11.8
Sulfonamides 738 12.7 86593 12.1 80.1 52.3 7.6 21.0 12.3 26.7
Fluoroquinolones 1131 19.4 21185 3.0 34.5 60.0 20.7 16.0 44.8 24.0
Cephalosporins 555 9.5 11257 1.6 35.9 78.1 16.8 9.3 47.4 12.7
Pleuromutilines 17 0.3 7314 1.0 35.3 3.0 58.8 97.0 5.9 0.0
All 5832 100.0 717175 100.0 44.7 64.9 20.2 16.0 35.1 19.0
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Ratios under 0.8 were regarded as “below recommended
dose” and those ratios above 1.25 were denoted as
“above recommended dose”. In the tables, results are
displayed as percentages of records and of nUDDs that
were below, within or above the respective recom-
mended dose.
46,201 complete records from pigs and cattle were
considered for analysis. Locally administered antibiotics
as well as incomplete records were excluded. For ana-
lyses per antimicrobial, the antimicrobials of prepara-
tions with two or three active ingredients were regarded
separately, leading to 58,923 antimicrobial-related data
set entries.Table 3 Percentages of records and nUDDs with doses below
pigs in a feasibility study of antibiotic use in Germany includ
Records %
nUDD % % Recor
Macrolides 1447 9.7 2107065 16.3 46.1
Beta-Lactams 4862 32.6 2906106 22.5 37.1
Aminoglycosides 626 4.2 157925 1.2 88.2
Fenicoles 491 3.3 22549 0.2 7.1
Tetracyclines 2814 18.9 3823986 29.6 33.9
Lincosamides 1032 6.9 564908 4.4 46.0
Polypeptides 593 4.0 1116686 8.6 34.9
Sulfonamides 749 5.0 1663887 12.9 54.6
Fluoroquinolones 1414 9.5 93777 0.7 14.9
Cephalosporins 466 3.1 42230 0.3 36.5
Pleuromutilines 424 2.8 428155 3.3 71.7
All 14918 100.0 12927274 100.0 38.8Descriptive statistical analyses, analyses of variance as
well as chi-square-statistics were carried out using SAS®,
Version 9.2 TS Level 1 M3 (SAS Institute Inc., Cary,
NC, USA). In order to compare the differences between
the percentage of records and the respective percentage
of nUDD per dose category, analyses of variance were
carried out.Results
In total, 57% of all records were related to pigs, resulting
in 96% of all nUDD and 94% of all nADD. Data for
piglets, sows and fattening pigs are summarized in
Tables 1, 2 and 3., within and above the recommended doses in fattening
ing 19 veterinary practices and 26 farms
Below Within Above
ds % nUDD % Records % nUDD % Records % nUDD
75.9 27.5 18.3 26.4 5.8
41.3 19.9 29.2 43.0 29.6
55.0 8.8 34.1 3.0 10.9
18.9 38.5 43.5 54.4 37.5
44.3 25.3 31.0 40.7 24.7
57.9 28.2 28.4 25.8 13.7
34.3 26.1 29.6 39.0 36.1
38.2 18.3 29.8 27.1 32.0
41.4 28.3 19.6 56.8 39.0
74.1 25.5 15.4 38.0 10.6
78.3 21.7 17.8 6.6 3.9
49.0 23.6 27.6 37.6 23.4
Table 4 Percentages of records and nUDDs with doses below, within and above the recommended doses in calves in a
feasibility study of antibiotic use in Germany including 19 veterinary practices and 26 farms
Records % Below Within Above
nUDD % % Records % nUDD % Records % nUDD % Records % nUDD
Macrolides 811 9.6 30229 2.7 9.4 8.2 38.5 27.9 52.2 63.9
Beta-Lactams 2176 25.7 146041 13.3 47.6 41.4 23.0 22.0 29.4 36.6
Aminoglycosides 1023 12.1 90515 8.2 55.7 61.2 29.2 30.7 15.1 8.1
Fenicoles 636 7.5 10934 1.0 46.9 73.8 27.2 15.8 25.9 10.4
Tetracyclines 892 10.5 333302 30.3 17.7 24.0 15.4 13.5 66.9 62.5
Polypeptides 231 2.7 44368 4.0 45.9 15.4 22.5 52.4 31.6 32.2
Sulfonamides 566 6.7 411779 37.5 28.1 23.6 22.4 30.3 49.5 46.1
Fluoroquinolones 1805 21.3 27814 2.5 31.6 63.7 24.4 13.6 44.0 22.7
Cephalosporins 339 4.0 4536 0.4 12.4 38.0 26.3 12.5 61.4 49.5
All 8479 100.0 1099518 100.0 35.6 30.0 25.1 24.3 39.3 45.7
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nUDD and 58% of all nADD. Beta-lactams and tetracy-
clines were used most often (nUDD) followed by sulfon-
amides & trimethoprim (Table 1). 48% of the records
and 50% of nUDD were above the recommended dose
(i.e. UDD/ADD-ratio above 1.25), and only 19% of
the records (20% of nUDD) were within the recom-
mended dose (i.e. UDD/ADD-ratio between 0.8 and 1.25).
Tetracyclines and polypeptides were more often above the
recommended dose than within or below the recom-
mended dose.
10% of all records, but only 2.6% of all nUDD and
1.7% of nADD were linked to sows (Table 2). All anti-
microbial classes were used to some extent below the
recommended dose, but 35% of the records showed
doses above the recommended dose. Differences be-
tween the percentage of records and the percentage of
nUDD were statistically significant (analysis of variance,
p-value 0.0038).Table 5 Percentages of records and nUDDs with doses below
cattle in a feasibility study of antibiotic use in Germany inclu
Records % B
nUDD % % Record
Macrolides 824 5.2 4538 5.3 35.1
Beta-Lactams 4737 29.7 22766 26.5 46.7
Aminoglycosides 1291 8.1 5300 6.2 68.2
Fenicoles 81 0.5 714 0.8 86.4
Tetracyclines 555 3.5 6243 7.3 42.7
Polypeptides 510 3.2 2366 2.8 58.6
Sulfonamides 1209 7.6 15926 18.5 88.5
Fluoroquinolones 2713 17.0 11780 13.7 21.9
Cephalosporins 4009 25.2 16309 19.0 33.8
All 15929 100.0 85942 100.0 44.0Fattening pigs accounted for the highest number of
records (25%) and of nUDD (46%) (34% of nADD)
(Table 3). Apart from sulfonamides & trimethoprim,
fenicoles, and polypeptides, all antimicrobials were used
below the recommended dose. 39% of the records were
below the recommended dose (49% of nUDD), 38%
above (23% of nUDD) (statistically significant differences
between% of records and% of nUDD in the analysis of
variance, p-value 0.0167).
14% of all records, but only 4% of all nUDD and 6% of
nADD related to calves (Table 4). Calves often received
higher doses than recommended. The frequently used
antimicrobial classes tetracyclines and sulfonamides &
trimethoprim had 63% and 46% of nUDD above the
recommended dose, respectively.
1.7% of records, 0.1% of nUDD and 0.05% of nADD
were linked to dairy cattle. Beta-lactams, cephalosporins
and sulfonamides & trimethoprim accounted for the
highest numbers of nUDD (Table 5). 44% of the records, within and above the recommended doses in dairy
ding 19 veterinary practices and 26 farms
elow Within Above
s % nUDD % Records % nUDD % Records % nUDD
60.8 49.4 33.5 15.5 5.7
64.6 26.3 20.2 26.9 15.2
70.4 17.3 20.0 14.6 9.6
96.2 12.3 3.6 1.2 0.1
36.1 9.5 12.2 47.7 51.7
83.8 19.0 10.5 22.4 5.7
68.4 3.5 20.1 8.0 11.5
55.5 36.7 20.7 41.4 23.8
36.0 35.9 37.7 30.3 26.3
57.5 28.4 23.3 27.6 19.2
Table 6 Percentages of records and nUDDs with doses below, within and above the recommended doses in beef cattle
in a feasibility study of antibiotic use in Germany including 19 veterinary practices and 26 farms
Records % Below Within Above
nUDD % % Records % nUDD % Records % nUDD % Records % nUDD
Macrolides 141 14.0 1132 6.0 57.4 56.9 35.5 37.1 7.1 6.0
Beta-Lactams 465 46.0 4698 25.0 71.6 90.3 18.1 7.2 10.3 2.5
Aminoglycosides 17 1.7 86 0.5 52.9 57.0 23.5 32.6 23.5 10.5
Fenicoles 114 11.3 1184 6.3 92.1 98.4 6.1 1.3 1.8 0.3
Tetracyclines 56 5.5 6233 33.1 50.0 15.6 12.5 6.9 37.5 77.5
Polypeptides 2 0.2 49 0.3 100.0 100.0 . . . .
Sulfonamides 16 1.6 4586 24.4 68.8 85.0 18.8 12.0 12.5 3.1
Fluoroquinolones 111 11.0 479 2.5 27.9 22.1 20.7 22.8 51.4 55.1
Cephalosporins 88 8.7 380 2.0 33.0 28.7 31.8 36.8 35.2 34.5
All 1010 100.0 18827 100.0 62.3 59.7 20.4 10.8 17.3 29.6
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(analysis of variance, p-value 0.0238). Only tetracyclines
were often above the recommended dose. Cephalospo-
rins and fluoroquinolones were less frequently below the
recommended dose than the other antimicrobials.
Only 2% of all records and 0.1% of all nUDD as well as
of all nADD were related to beef cattle (Table 6). For most
antimicrobial classes treatments were often below the
recommended dose, but treatments with tetracyclines,Table 7 Percentages of records and nUDDs with doses below
administration route and animal group in a feasibility study
practices and 26 farms
Records %
nUDD % % R
Piglets Parenteral 7090 55.6 1366875 10.4
Oral 5665 44.4 11761033 89.6
All 12755 100.0 13127908 100.0
Sows Parenteral 5143 88.2 112166 15.6
Oral 689 11.8 605009 84.4
All 5832 100.0 717175 100.0
Fattening Pigs Parenteral 8912 59.7 626469 4.8
Oral 6006 40.3 12300805 95.2
All 14918 100.0 12927274 100.0
Calves Parenteral 6573 77.5 120400 11.0
Oral 1906 22.5 979118 89.0
All 8479 100.0 1099518 100.0
Dairy Cattle Parenteral 15851 99.5 69855 81.3
Oral 78 0.5 16087 18.7
All 15929 100.0 85942 100.0
Beef Cattle Parenteral 966 95.6 6657 35.4
Oral 44 4.4 12170 64.6
All 1010 100.0 18827 100.0fluoroquinolones and cephalosporins were rarely below
the recommended dose.
The majority of nUDD were administered orally to
pigs as well as to cattle (Table 7). In pigs, the distribu-
tion of records and nUDD regarding the dose categories
differed only slightly between parenteral and oral appli-
cations. Only in fattening pigs were oral applications
more frequently below the recommended dose than par-
enteral applications (chi-square-test, p-value < 0.0001)., within and above the recommended doses per
of antibiotic use in Germany including 19 veterinary
Below Within Above
ecords % nUDD % Records % nUDD % Records % nUDD
34.9 47.8 17.8 16.2 47.3 36.0
30.3 28.1 20.1 20.6 49.6 51.3
32.9 30.2 18.8 20.2 48.3 49.7
44.9 74.9 20.0 11.9 35.1 13.3
43.1 63.1 21.6 16.8 35.3 20.1
44.7 64.9 20.2 16.0 35.1 19.0
35.0 62.5 21.4 15.1 43.6 22.4
44.4 48.3 26.8 28.2 28.8 23.4
38.8 49.0 23.6 27.6 37.6 23.4
37.4 69.7 27.1 15.1 35.5 15.2
29.2 25.1 18.2 25.5 52.6 49.4
35.6 30.0 25.1 24.3 39.3 45.7
44.0 58.5 28.4 23.6 27.6 17.9
44.9 53.2 16.7 22.1 38.5 24.7
44.0 57.5 28.4 23.3 27.6 19.2
63.4 75.6 20.4 15.3 16.3 9.1
38.6 51.0 20.5 8.3 40.9 40.7
62.3 59.7 20.4 10.8 17.3 29.6
Table 8 Percentages of records and nUDDs with doses below, within and above the recommended doses per
indication and animal group in a feasibility study of antibiotic use in Germany including 19 veterinary practices and
26 farms













Piglets Respiratory disease 5093 39.9 5904075 45.0 24.1 18.2 23.7 24.1 52.2 57.6
Skin disease 303 2.4 106938 0.8 48.2 30.7 21.5 19.8 30.4 49.5
Enteric disease 2914 22.8 4154307 31.6 33.5 33.8 18.1 18.9 48.4 47.3
Articular disease 688 5.4 113860 0.9 76.0 80.7 6.7 6.3 17.3 13.1
CNS disease 11 0.1 2554 0.0 18.2 78.3 18.2 7.9 63.6 13.8
Reproductive system
disease
22 0.2 49900 0.4 40.9 72.9 36.4 16.6 22.7 10.5
Other 3722 29.2 2796054 21.3 35.1 47.1 14.6 14.3 50.3 38.6
All 12753 100.0 13127688 100.0 32.9 30.2 18.8 20.2 48.3 49.7
Sows Respiratory disease 991 17.0 175959 24.5 57.0 73.6 20.2 18.0 22.8 8.3
Skin disease 34 0.6 526 0.1 47.1 42.8 14.7 35.9 38.2 21.3
Enteric disease 171 2.9 77547 10.8 50.3 67.2 21.6 19.7 28.1 13.0
Articular disease 161 2.8 1907 0.3 32.3 62.6 24.2 15.5 43.5 21.9
CNS disease 1 0.0 3 0.0 . . 100.0 100.0 . .
Udder disease 66 1.1 377 0.1 39.4 45.4 21.2 15.1 39.4 39.5
Reproductive system
disease
2428 41.6 69830 9.7 47.9 57.8 11.5 12.7 40.6 29.5
Other 1980 34.0 391026 54.5 35.3 61.9 30.5 15.0 34.2 23.1
All 5832 100.0 717175 100.0 44.7 64.9 20.2 16.0 35.1 19.0
Fattening pigs Respiratory disease 8273 55.5 6138179 47.5 37.3 42.0 23.9 29.0 38.8 29.0
Skin disease 643 4.3 52603 0.4 29.5 66.8 11.8 19.9 58.6 13.2
Enteric disease 2539 17.0 4931365 38.2 50.6 56.2 26.9 27.1 22.4 16.7
Articular disease 511 3.4 15563 0.1 38.4 77.7 15.5 8.6 46.2 13.6
CNS disease 2 0.0 80 0.0 100.0 100.0 . . . .
Reproductive system
disease
66 0.4 51465 0.4 43.9 95.1 21.2 3.5 34.8 1.4
Other 2881 19.3 1731489 13.4 34.5 50.9 23.8 25.5 41.7 23.6
All 14915 100.0 12920744 100.0 38.8 49.0 23.6 27.6 37.6 23.4
Calves Respiratory disease 4624 54.6 794350 72.2 27.2 26.5 26.1 22.6 46.7 50.9
Skin disease 92 1.1 490 0.0 44.6 32.7 12.0 11.8 43.5 55.5
Enteric disease 1586 18.7 175228 15.9 51.5 48.1 21.1 27.6 27.4 24.3
Articular disease 216 2.6 3528 0.3 64.8 83.1 18.5 10.3 16.7 6.5
CNS disease 10 0.1 25 0.0 30.0 12.0 10.0 4.0 60.0 84.0
Reproductive system
disease
1 0.0 2 0.0 . . . . 100.0 100.0
Other 1936 22.9 125851 11.4 39.0 25.2 27.7 31.0 33.3 43.8
All 8465 100.0 1099474 100.0 35.6 30.0 25.1 24.3 39.3 45.7
Dairy cattle Respiratory disease 1497 9.4 20123 23.4 60.8 64.4 18.8 21.3 20.4 14.3
Skin disease 893 5.6 3840 4.5 27.1 30.2 34.9 38.8 38.0 31.0
Enteric disease 202 1.3 2678 3.1 54.5 81.1 26.7 8.4 18.8 10.5
Articular disease 728 4.6 3115 3.6 27.2 32.5 38.2 41.4 34.6 26.0
CNS disease 4 0.0 4 0.0 50.0 50.0 25.0 25.0 25.0 25.0
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Table 8 Percentages of records and nUDDs with doses below, within and above the recommended doses per
indication and animal group in a feasibility study of antibiotic use in Germany including 19 veterinary practices and
26 farms (Continued)
Udder disease 6394 40.1 21296 24.8 38.2 45.8 31.2 31.0 30.6 23.2
Reproductive system
disease
1386 8.7 5214 6.1 55.0 60.2 19.4 16.8 25.6 23.0
Other 4825 30.3 29672 34.5 48.5 64.8 27.5 17.6 23.9 17.5
All 15929 100.0 85942 100.0 44.0 57.5 28.4 23.3 27.6 19.2
Beef cattle Respiratory disease 489 48.4 12270 65.2 64.8 54.3 18.0 10.4 17.2 35.2
Skin disease 55 5.4 201 1.1 41.8 32.8 40.0 46.8 18.2 20.4
Enteric disease 13 1.3 1590 8.4 38.5 93.4 30.8 5.9 30.8 0.7
Articular disease 158 15.6 1333 7.1 74.1 89.3 16.5 8.6 9.5 2.1
Reproductive system
disease
4 0.4 4 0.0 75.0 75.0 25.0 25.0 . .
Other 291 28.8 3429 18.2 56.4 53.2 22.3 12.9 21.3 33.9
All 1010 100.0 18827 100.0 100.0 59.7 20.4 10.8 17.3 29.6
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http://www.biomedcentral.com/1746-6148/10/7In cattle, oral applications were more often above the
recommended dose, whereas most of the doses of paren-
teral applications were below the recommended dose.
Differences regarding the dose category between oral
and parenteral applications (records) were statistically
significant (chi-square-test, p-value < 0.0001).
Predominant indications for antimicrobial agents used
in this study were respiratory diseases, as intestinal
diseases (Table 8). Apart from sows and dairy cattle, the
percentage of records below the recommended dose
was higher regarding enteric diseases than respiratory
diseases (chi-square-test, p-value < 0.0001 for piglets,
fattening pigs and calves).
Tables 9 and 10 summarize the distribution of the
used dosages and the respective recommended dosage
per antimicrobial and per administration route for pigs
and cattle respectively. For pigs and cattle differently, for
a few antimicrobials the used dosages were frequently
below the respective recommended dosage. In pigs, only
spectinomycin and pleuromutilines showed lower
dosages than recommended, whereas oxytetracycline
was frequently used above the recommended dosage. In
cattle, tetracycline was frequently used above the recom-
mended dosage, while for ampicillin, spectinomycin, and
sulfonamides & trimethoprim used dosages were below
the recommended dosage.
Discussion
In the present study, it was possible to determine the
nUDD, nADD as well as the UDD and the UDD/ADD-
ratio on the basis of an ADD. This complements farm
related data, calculated per animal under risk, which are
published by Merle et al. [15].
The proportions of the antimicrobial classes applied or
prescribed in our study were similar to those reported inother countries and with sales data [33]. Tetracyclines,
sulfonamides and beta-lactam-antibiotics are used fre-
quently all over Europe [12-14].
To analyze the exposure of animals with antimicro-
bials and the related selection pressure, the number of
individual applications of antimicrobials is more useful
information than the amount of antimicrobials used.
This is especially true for estimating the impact on anti-
microbial resistance selection, as this depends very much
on the frequency and length of selection pressure [2].
Therefore, the nUDD displays the frequency of use
much better and should be utilized when comparing
usage of different antimicrobials and antimicrobial
classes.
Other European countries that cannot calculate the
nUDD due to lack of detailed data, approximate the
number of applications by the Defined Animal Daily
Doses ADD which is calculated by the amount of active
ingredients, estimated standard live weights and recom-
mended dosages [10,11,21]. As far as the population at
risk and the amount of active ingredients per antimicro-
bial used in the individual animal population is known,
the number of standardized doses per animal or per kg
live weight can be calculated. By this means, data from
different countries, regions or time periods can be com-
pared directly. Thus, this variable is recommended by
EMA for monitoring purposes [8].
Trends over time, between antimicrobial classes or
animal species can be observed easily by the nUDD as
well as the nADD. While the nUDD is evaluated by the
veterinarians’ records and thus pictures the real number
of used daily doses, the nADD displays an estimate of
the number of daily doses. The major drawback is that
the calculation of the nADD depends on how precise
the animals treated had the estimated standard live
Table 9 Used and recommended dosages per antimicrobial and administration route in pigs in a feasibility study of
antibiotic use in Germany including 19 veterinary practices and 26 farms
Used dosage Recommended
dosageRecords 25%-Quartile Median 75%-Quartile
Macrolides Acetylisovaleryltylosin Oral 2 3.7 3.7 3.7 3.0
Erythromycin Parenteral 17 11.1 13.3 16.7 22.0
Tilmicosin Oral 110 7.1 12.3 19.0 20.0
Tulathromycin Parenteral 547 2.0 4.0 8.0 2.5
Tylosin Parenteral 749 12.5 17.5 24.0 15.0
Oral 1169 8.5 12.1 19.2 17.0
Beta-Lactames Amoxicillin Parenteral 2249 13.9 18.5 30.0 10.0
Oral 2792 20.0 34.8 57.1 30.0
Ampicillin Parenteral 453 8.0 12.1 20.0 37.0
Oral 11 0.3 11.2 31.6 45.0
Benzylpenicillin-Procaine Parenteral 4407 12.0 22.9 36.0 20.0
Benzylpenicillin-Benzathine Parenteral 1661 5.6 7.6 14.5 20.0
Aminoglycosides Apramycin Oral 103 3.4 5.6 16.9 15.0
Gentamicin Parenteral 332 3.3 5.6 10.2 6.0
Kanamycin Parenteral 2 6.9 13.5 20.0 15.0
Neomycin Parenteral 209 4.9 11.7 29.2 7.0
Oral 164 8.5 14.0 14.0 7.0
Spectinomycin Parenteral 900 9.1 13.0 19.6 30.0
Fenicoles Florfenicol Parenteral 727 15.0 20.0 30.0 15.0
Tetracyclines Chlortetracycline Oral 1062 18.6 33.2 73.7 40.0
Doxycycline Oral 35 7.9 11.1 20.0 15.0
Oxytetracycline Parenteral 1365 16.7 25.0 36.0 15.0
Oral 281 22.9 34.3 53.3 80.0
Tetracycline Oral 2529 38.5 56.6 77.6 50.0
Lincosamides Lincomycin Parenteral 1269 5.0 9.8 11.1 10.0
Oral 485 3.8 6.5 12.4 10.0
Polypeptides Colistin Parenteral 368 0.8 1.5 2.5 2.5
Oral 1672 3.8 6.9 13.9 5.0
Sulfonamides Sulfadimidine Oral 425 15.0 25.0 80.0 75.0
Sulfamethoxpyridazine Parenteral 5 57.9 57.9 57.9 60.0
Fluoroquinolones Danofloxacin Parenteral 846 1.7 2.1 2.5 1.3
Enrofloxacin Parenteral 1419 2.8 4.0 6.0 3.5
Oral 140 1.0 1.1 1.7 1.7
Marbofloxacin Parenteral 1022 1.9 2.4 3.7 2.0
Cephalosporins Cefquinome Parenteral 1143 1.1 1.7 2.5 1.5
Ceftiofur Parenteral 375 2.0 4.0 6.7 3.0
Pleuromutilines Tiamulin Parenteral 214 8.0 11.1 16.0 15.0
Oral 477 6.8 10.1 13.5 15.0
Valnemulin Oral 5 0.6 0.7 0.9 9.0
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Table 9 Used and recommended dosages per antimicrobial and administration route in pigs in a feasibility study of
antibiotic use in Germany including 19 veterinary practices and 26 farms (Continued)
Sulfonamides & trimethoprim Sulfadiazine Oral 877 25.6 34.3 47.6 25.0
Sulfadimethoxine Oral 13 31.6 42.9 150.0 17.0
Sulfadimidine Parenteral 796 19.2 30.0 44.4 75.0
Oral 5 5.5 9.6 32.7 75.0
Sulfadoxine Parenteral 70 10.0 17.8 26.7 16.0
Oral 3 9.6 12.1 50.7 16.0
Merle et al. BMC Veterinary Research 2014, 10:7 Page 10 of 13
http://www.biomedcentral.com/1746-6148/10/7weight and were treated exactly with the recommended
dosage. If the nADD and the nUDD differ the presump-
tion that the veterinarian chose the wrong dosage would
not be appropriate. Although it can be expected that for
a large population, e.g., all animals within a country, the
nUDD is similar to the nADD (because the estimated
standard live weight should represent the average live
weight of the treated animals), this will probably not be
the case for results on an individual farm, e.g., because
the average live weight of treated animals in this farm
may differ from the estimated standard live weight. Fur-
thermore, as production systems may vary considerably
between countries, a systematic bias may be introduced
by calculating nADDs based on European standard live
weights for animal species/production types.
In our study we calculated the nADD according to the
Danish procedure [22,30] and compared them to the
nUDD as collected within our study. Regarding the esti-
mated standard live weights we followed the Dutch calcu-
lation method [32], because the live weights used seemed
to fit better to the German situation (expert opinion).
For piglets and calves most of the UDDs were above
the recommended dose, while regarding sows, fattening
pigs, dairy and beef cattle, most of the UDDs were lower
than the respective ADD. Possibly the young animals
treated had higher live weights than the estimated stand-
ard weight (underestimation of standard live weights
results in underestimation of ADD) or they received
higher dosages depending on the health status.
The frequent high percentage of records above the
recommended dose concerning tetracyclines in almost
all age groups (except sows and fattening pigs) can
indicate evidence based adaption of dosages by the
veterinarians. For some pharmaceuticals the dosages
recommended by the manufacturer are below the
dosages recommended in current literature, because they
were authorized many years ago and the pathogen’s
susceptibility changed since then.
In sows, the percentage of nUDD below the recom-
mended dose was high compared to the other production
types. It has to be suggested that the estimated standard
live weight of 220 kg for sows is too high, because sows
more often receive individual or parenteral treatmentswith usually precise dosages than other animal groups.
Thus it seems to be more likely that the used dose UDD
was correct, but the recommended dose ADD was
calculated too high basing on the estimated live weight.
Likewise fattening pigs that are treated with an antimicro-
bial are most probably lower in weight than 70.2 kg, and
thus the percentage of nUDD below the recommended
dose reached 49% in this study. It is noticeable that the
percentage of records below the recommended dose was
statistically significant lower than the respective nUDD for
fattening pigs and sows as well as for dairy cattle. This
means that treatments of numerous animals are more
likely to be underdosed than records concerning few
animals.
In calves, frequent underdosing was only observed for
aminoglycosides, fluoroquinolones and fenicoles, pos-
sibly indicating higher live weights than the estimated
80 kg. The frequently used cephalosporins (often applied
for udder diseases) for dairy cattle were applied below
the recommended dose only in 36% of nUDD, and thus
can be regarded as being within the recommended dose.
Fluoroquinolones were used in dairy cattle below the
recommended dose only in 22% of records, but in 56%
of nUDD. This is a hint that treatment of single animals
(e.g. treating udder diseases) are dosed within or above
the recommended dose while group treatments (several
animals per record) often are dosed below the recom-
mended dose, although all treatments were administered
parenterally.
To quote the use of antimicrobials knowledge of
the medical indication is crucial. Respiratory and intestinal
diseases are very common in livestock husbandry, because
they are often caused by rather contagious pathogens
which are frequently distributed within and between
herds. The fact that the percentage of nUDD below the
recommended dose was lower regarding enteric diseases
than respiratory diseases may be related to the age of the
animals: young animals often suffer from diarrhea, re-
spiratory diseases also occur in older animals, e.g., fatten-
ing pigs at the end of their life. Therefore additional data
concerning the treated animals are required in order to
avoid the uncertainty of calculations of ADDs due to
misestimation of live weights.
Table 10 Used and recommended dosage per antimicrobial and administration route in cattle in a feasibility study of
antibiotic use in Germany including 19 veterinary practices and 26 farms
Used dosage Recommended
dosageRecords 25%-Quartile Median 75%-Quartile
Macrolides Erythromycin Parenteral 142 10.0 10.0 13.3 11.0
Tilmicosin Parenteral 171 7.5 10.9 15.0 10.0
Oral 11 28.1 31.6 37.5 20.0
Tulathromycin Parenteral 878 2.0 2.5 4.0 2.5
Tylosin Parenteral 561 10.0 13.3 14.2 15.0
Oral 13 19.4 33.9 56.0 17.0
Beta-Lactames Amoxicillin Parenteral 1648 7.5 10.0 16.0 10.0
Oral 370 13.5 25.0 44.4 30.0
Ampicillin Parenteral 452 7.6 10.0 13.6 37.0
Oral 3 18.8 25.0 25.0 45.0
Benzylpenicillin-Procaine Parenteral 3027 10.0 15.0 24.0 20.0
Benzylpenicillin Parenteral 7 18.0 18.0 18.0 20.0
Benzylpenicillin-Benzathine Parenteral 846 4.8 9.1 11.9 20.0
Penethamathydrojodid Parenteral 1025 9.6 19.1 19.1 10.0
Aminoglycosides Gentamicin Parenteral 778 3.3 5.1 6.4 6.0
Kanamycin Parenteral 3 5.0 5.0 10.0 15.0
Neomycin Parenteral 524 5.3 7.0 13.1 7.0
Oral 52 4.1 5.6 10.5 7.0
Spectinomycin Parenteral 974 5.9 9.8 12.5 20.0
Fenicoles Florfenicol Parenteral 831 15.0 20.4 37.5 30.0
Tetracyclines Chlortetracycline Oral 426 35.3 60.3 92.9 40.0
Oxytetracycline Parenteral 666 10.0 17.3 20.0 15.0
Oral 58 22.1 34.5 41.7 80.0
Tetracycline Oral 353 41.3 66.0 82.5 20.0
Polypeptides Colistin Parenteral 622 1.0 1.3 2.6 2.5
Oral 121 5.1 7.1 14.3 5.0
Sulfonamides Sulfadimidine Oral 31 34.7 78.1 110.4 75.0
Sulfamethoxpyridazine Parenteral 3 60.0 62.5 62.5 60.0
Fluoroquinolones Danofloxacin Parenteral 587 1.7 2.3 4.5 1.3
Difloxacin Parenteral 102 5.2 6.9 10.4 2.5
Enrofloxacin Parenteral 2600 2.5 3.8 5.2 3.5
Oral 29 1.6 3.1 3.5 3.5
Marbofloxacin Parenteral 1208 1.3 2.4 3.1 2.0
Oral 103 0.6 0.6 0.6 2.0
Cephalosporins Cefquinome Parenteral 2283 1.2 1.3 1.9 1.5
Ceftiofur Parenteral 2153 1.4 1.7 2.0 1.5
Sulfonamides & Trimethoprim Sulfadiazine Oral 405 21.9 33.5 55.8 25.0
Sulfadimethoxine Oral 52 15.0 37.5 60.9 17.0
Sulfadimidine Parenteral 988 24.0 28.8 28.8 75.0
Oral 1 45.0 45.0 45.0 75.0
Sulfadoxine Parenteral 311 12.0 12.0 24.0 16.0
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http://www.biomedcentral.com/1746-6148/10/7Respective infections are treated herdwise in order
to treat all animals that are likely to be infected
(metaphylaxis). In large herds (pigs and poultry), oral
treatment via feed or water is the most common form
of administration, because animals that still take up
feed or water can be easily reached and individual
treatment by injection would be stressful for them.
The guidelines of antibiotic treatment and those for
oral application of drugs to farm animals emphasize
the prudent use of antibiotic treatment [4].
It was expected that parenteral treatment was dosed
more precisely than oral treatment. This could be
shown by comparing used and recommended doses.
In cattle, a respective trend could be seen. 28% of re-
cords for parenteral treatment vs. 18% for oral treat-
ment were within the recommended dose, although
regarding the nUDD the percentage of applications
within the recommended dose was higher for oral
than for parenteral applications (18% and 25% of
nUDD, respectively). 29% of parenteral applications
(records) of cattle were above the recommended dose
while doses in oral treatments were more often (52%)
above the recommended doses. Underdosage of anti-
microbials was detected in about 42% of all records
from cattle, these results corresponding to the find-
ings of other authors [25,26]. Ampicillin, spectino-
mycin and sulfonamides & trimethoprim seemed to
be underdosed regularly, while tetracyclines were fre-
quently used above the recommended dosage.
In pigs, the dosages used varied widely compared to
the recommended dosage. 38% of records were below,
41% above and only 21% within the recommended
dose. Results differed only slightly between age groups
and administration routes. Nonetheless, the recom-
mended dosage was within the 25%-quartile and the
75%-quartile of the used dosages for most of the anti-
microbials. The fact that tetracyclines were used
regularly above the recommended dosage in pigs and
in cattle may be reflected in the fact that veterinar-
ians prescribe higher doses due to previous treatment
failures. As current practice does not lead to regular
update of SPCs, new mechanisms should be estab-
lished to ensure proper treatment recommendations
on the SPCs. The newer antimicrobials: macrolides,
fluoroquinolones and pleuromutilines were often ap-
plied within the recommended dosage.
Nonetheless, the evaluation of the true implications
of these findings on the development of antimicrobial
resistance is limited, because the assessment of pru-
dent use requires detailed information that is not fully
available from monitoring data. Thus, monitoring data
can be used to observe trends in the dosage applied
and to initiate a reassessment of the current dosage
recommendation.Conclusions
Proper investigation of antibiotic use is challenging. By
calculating and comparing UDDs and the respective
ADD it is possible to estimate the impact of treatments
regarding the risk for the selection of resistant bacteria.
This approach can serve as a general overview of dosage
patterns and may be able to reveal differences between
countries or time periods. Nevertheless, it cannot be
used to assess the dosage patterns of single treatments,
because differences between UDD and ADD may be due
to the animal live weight or the individual health
conditions.
A longitudinal evaluation of antibiotics use in animals
plays an important role in controlling resistance. Com-
bining consumption data with those of the spread of
resistant bacteria will help to bring resistance prevention
and control a step forward.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MR, C H-G and YM carried out the feasibility study and recorded the data
from the farmers and veterinarians. MR evaluated the pharmacological
aspects of the study. C H-G analyzed the data from the veterinary practices,
and YM the data from the farmers. RM and PH designed the study. PH
prepared the study database, RM co-ordinated and supervised the statistical
analyses. AK, WH and LK applied for grants, co-ordinated the study and were
involved in drafting the manuscript. All authors read and approved the
final manuscript.
Acknowledgments
This study was funded by the Federal Institute for Risk Assessment and has
the number 1329–441. We would like to thank the veterinarians and farmers
who took part in the study as well as Dr. Sylvia Heesen from the veterinary
authority of the district Kleve for her assistance.
Author details
1Department of Biometry, Epidemiology and Information Processing,
University of Veterinary Medicine Hannover, WHO-Centre Veterinary Public
Health, Bünteweg 2, Hannover D-30559, Germany. 2Veterinary Faculty of
Universität Leipzig, Institute for Pharmacology, Pharmacy and Toxicology, An
den Tierkliniken 15, Leipzig D-04103, Germany. 3Department Biological
Safety, Federal Institute for Risk Assessment, Max-Dohrn-Str. 8-10, Berlin
10589, Germany.
Received: 20 March 2013 Accepted: 31 December 2013
Published: 8 January 2014
References
1. Schwarz S, Kehrenberg C, Walsh TR: Use of antimicrobial agents in
veterinary medicine and food animal production. Int J Antimicrob Agents
2001, 17(6):431–437.
2. Aarestrup FM: Association between the consumption of antimicrobial
agents in animal husbandry and the occurrence of resistant bacteria
among food animals. Int J Antimicrob Agents 1999, 12(4):279–285.
3. Ungemach F-R, Müller-Bahrdt D, Abraham G: Guidelines for prudent use of
antimicrobials and their implications on antibiotic usage in veterinary
medicine. Int J Med Microb 2006, 296(S2):33–38.
4. Bundestierärztekammer, Arbeitsgruppe Tierarzneimittel (AGTAM) der
Länderarbeitsgemeinschaft Verbraucherschutz: [Guidelines for the prudent
use of antimicrobial effective veterinary drugs including comments –
antibiotics guideline]. Dtsch Tierärzteblatt 2010, 2010(11). Supplement.
5. EFSA Panel on Biological Hazards (BIOHAZ): Joint Opinion on antimicrobial
resistance (AMR) focused on zoonotic infections. EFSA J 2009, 7(11):78.
Merle et al. BMC Veterinary Research 2014, 10:7 Page 13 of 13
http://www.biomedcentral.com/1746-6148/10/76. Bundesministerium für Gesundheit, Bundesministerium für Ernährung,
Landwirtschaft und Verbraucherschutz, Bundesministerium für Bildung und
Forschung: [DART German Antibiotic Resistance Strategy]. Berlin, Germany:
Bundesministerium für Gesundheit, Bundesministerium für Ernährung,
Landwirtschaft und Verbraucherschutz, Bundesministerium für Bildung und
Forschung; 2011:1–112.
7. European Medicines Agency: Trends in the sales of veterinary antimicrobial
agents in nine European countries. Reporting period: 2005–2009. London,
United Kingdom: European Medicines Agency; 2011:1–77.
8. Grave K, Greko C, Kvaale MK, Torren-Edo J, Mackay D, Muller A, Moulin G, on
behalf of the ESVAC Group: Sales of veterinary antibacterial agents in nine
European countries during 2005–09: trends and patterns. J Antimicrob
Chemoth 2012, 67(12):3001–3008.
9. Grave K, Torren-Edo J, Mackay D: Comparison of the sales of veterinary
antibacterial agents between 10 European countries. J Antimicrob
Chemoth 2010, 65(9):2037–2040.
10. European Medicines Agency: Sales of veterinary antimicrobial agents in 19
EU/EEA countries in 2010. London, United Kingdom: European Medicines
Agency; 2012:1–74.
11. European Medicines Agency: Sales of veterinary antimicrobial agents in 25
EU/EEA countries in 2011. London, United Kingdom: European Medicines
Agency; 2013:1–98.
12. Agersø Y, Andersen VD, Helwigh B, Hog BB, Jensen LB, Jensen VF,
Korsgaard H, Larsen LS, Pedersen K, Seyfarth AM, et al: In DANMAP
2012 - Use of antimicrobial agents and occurrence of antimicrobial
resistance in bacteria from food animals, food and humans in Denmark.
Edited by Korsgaard H, Hog BB, Agersø Y. Kopenhagen, Denmark:
Statens Serum Institut; 2013:1–120.
13. Hellman J, Olsson-Liljequist B: SWEDRES / SWEDVARM 2012: Swedish
Antibiotic Utilisation and Resistance in Human Medicine Swedish Veterinary
Antimicrobial Resistance Monitoring. Solna, Uppsala / Sweden: Swedish
Institute for Communicable Disease Control and National Veterinary
Institute; 2013:1–108.
14. Simonsen G, Urdahl AM: NORM NORM-VET 2012:Usage of Antimicrobial
Agents and Occurrence of Antimicrobial Resistance in Norway. Tromso,
Oslo/Norway: Norwegian Veterinary Institute; 2013:1–95.
15. Merle R, Hajek P, Käsbohrer A, Hegger-Gravenhorst C, Mollenhauer Y,
Robanus M, Ungemach F-R, Kreienbrock L: Monitoring of antibiotic
consumption in livestock: a German feasibility study. Prev vet med 2012,
104(1–2):34–43.
16. Büttner S, Flechtner O, Müntener C, Overesch G: [ARCH-Vet General report
2011: Antibiotics in veterinary medicine and antibiotic resistance monitoring in
farm animals in Switzerland.]. Bern, Switzerland: Bundesamt für
Veterinärwesen, Swissmedic Schweizerisches Heilmittelinstitut; 2012:1–81.
17. Sheehan R, Walker S, Eckford S: UK veterinary antibiotic resistance and
sales surveillance 2012. In Edited by Borellio SP. Surrey, United Kingdom:
Veterinary Medicines Directorate; 2013:1–104.
18. Chevance A, Moulin G, French Agency for Food. Environmental and
Occupational Health & Safety (ANSES), French Agency for Veterinary
Medicinal Products (ANMV): In Sales survey of veterinary medicinal products
containing antimicrobials in France - 2011. Edited by French Agency for
Food EaOHSA. Cedex, France: French Agency for Food, Environmental and
Occupation Health & Safety ANSES; 2012:1–73.
19. Bundesversammlung der schweizerischen Eidgenossenschaft: Federal law of
drugs and medicinal products. Switzerland: Bundesversammlung der
schweizerischen Eidgenossenschaft; 2000. 81221.
20. Nationalrat Österreich: Federal law of the production and the marketing of
drugs. Nationalrat, 185. Wien, Austria: Verlagspostamt; 1983.
21. Mevius DJ, Koene MGJ, Wit B, Van Pelt W, Bondt N: MARAN 2009: Monitoring
of antimicrobial resistance and antibiotic usage in animals in the Netherlands
in 2009. Lelystad, NL: Central Veterinary Institute; 2011:70.
22. Jensen VF, Jacobsen E, Bager F: Veterinary antimicrobial-usage statistics
based on standardized measures of dosage. Prev vet med 2004,
64(2–4):201–215.
23. Blaha T, Meemken D, Dickhaus CP, Klein G: [Proposals for designing the
food chain information for the implementation of the risk-oriented
ante- and post-mortem meat inspection]. Dtsch Tierärztl Wschr 2007,
114(8):309–316.
24. WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for
ATC classification and DDD assignment 2010. In Edited by Methodology
WCCfDS. Oslo, Norway; 2009:1–282.25. Persoons D, Dewulf J, Smet A, Herman L, Heyndrickx M, Martel A, Catry B,
Butaye P, Haesebrouck F: Antimicrobial use in Belgian broiler production.
Prev vet med 2012, 105:320–325.
26. Regula G, Torriani K, Gassner B, Stucki F, Müntener CR: Prescription patterns
of antimicrobials in veterinary practices in Switzerland. J Antimicrob
Chemoth 2009, 63(4):805–811.
27. Menéndez González S, Steiner A, Gassner B, Regula G: Antimicrobial use in
Swiss dairy farms: quantification and evaluation of data quality. Prev vet
med 2010, 95(1–2):50–63.
28. Pardon B, Catry B, Dewulf J, Persoons D, Hostens M, De Bleecker K, Deprez
P: Prospective study on quantitative and qualitative antimicrobial and
anti-inflammatory drug use in white veal calves. J Antimicrob Chemoth
2012, 67(4):1027–1038.
29. Callens B, Persoons D, Maes D, Laanen M, Postma M, Boyen F, Haesebrouck
F, Butaye P, Catry B, Dewulf J: Prophylactic and metaphylactic
antimicrobial use in Belgian fattening pig herds. Prev vet med 2012,
106(1):53–62.
30. European Surveillance of Veterinary Antimicrobial Consumption (ESVAC)
group: ESVAC reflection paper on collecting data on consumption of
antimicrobial agents per animal species, on technical units of
measurement and indicators for reporting consumption of antimicrobial
agents in animals. Draft. In EMA/286416/2012-CONSULTATION. London,
United Kingdom: European Medicines Agency EMA; 2012:1–28.
31. Bundesministerium für Jugend Familie und Gesundheit BVBl. I: Regulation of
the veterinary pharmacies as amended on the announcement of July, 8, 2009
(TÄHAV). Berlin, Germany: Bundesministerium für Jugend, Familie und
Gesundheit; 2009:1760–1769.
32. Mevius DJ, Wit B, van Pelt W: MARAN-2007 - Monitoring of antimicrobial
resistance and antibiotic usage in animals in The Netherlands in 2006/2007.
Lelystand/NL: Central Veterinary Institute of Wageningen UR, Lelystad, The
Netherlands; 2008:104.
33. Wallmann J, Reimer I, Römer A, Bender A, Heberer T: Evaluation of sales
data of antimicrobial effective substances in Germany in 2011.
Dtsch Tierärzteblatt 2013, 61(9):1230–1234.
doi:10.1186/1746-6148-10-7
Cite this article as: Merle et al.: Feasibility study of veterinary antibiotic
consumption in Germany - comparison of ADDs and UDDs by animal
production type, antimicrobial class and indication. BMC Veterinary
Research 2014 10:7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
